While potty training is probably a distant childhood memory, the panicked feeling of “I need to pee right now and I don’t know if I can make it to the bathroom in time” is something many adults still ...

Standard stepwise therapy for overactive bladder (OAB) begins with conservative therapies such as lifestyle interventions and behavioral approaches. Medications—anticholinergics or beta-3 agonists—are ...

Medtech companies are increasingly investing in neuromodulation to treat UUI, which is estimated to impact 20% of adults ...

Women with overactive bladder are frequently frustrated with treatment, which leads to discontinuation of therapy. Asynchronous telehealth visits keep women engaged in follow-up care, accelerates ...

Overactive bladder is a long-term condition that won’t go away on its own and may worsen if a person does not get treatment. The condition can be caused by issues in how the brain and bladder ...

Backed by IBF, Merz, and Laborie, Vensica to Advance Needle-Free Delivery of Botulinum Toxin A (Xeomin ®) for Minimally Invasive Treatment BROOKLYN, N.Y., Oct. 28, 2024 /PRNewswire/ -- Vensica Medical ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The novel muscarinic M3 receptor antagonist DA8010 ...

The "Overactive Bladder Treatment Market by Pharmacotherapy and Disease Type - Global Forecast to 2022" report has been added to Research and Markets' offering. The global overactive bladder treatment ...

NEW YORK, Oct. 21, 2022 /PRNewswire/ -- The Insight Partners published latest research study on "Overactive Bladder Treatment Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast ...